Lymphocytic Adenohypophysitis Simulating a Pituitary Adenoma in a Pregnant Woman by J. Talan-Hranilović et al.




Simulating a Pituitary Adenoma
in a Pregnant Woman
B. Vizner1, J. Talan-Hranilovi}2, @. Gnjidi}3, M. Sekso1, M. Berkovi}1,
V. Altabas1 and Z. Rumboldt4
1 Department of Neuroendocrinology and Pituitary Diseases, University Hospital
»Sestre milosrdnice«, Zagreb, Croatia
2 Department of Pathology, University Hospital »Sestre milosrdnice», Zagreb, Croatia
3 Department of Neurosurgery, University Hospital »Sestre milosrdnice», Zagreb, Croatia
4 Department of Radiology, University Hospital »Sestre milosrdnice», Zagreb, Croatia
A B S T R A C T
The lymphocytic hypophysitis, appearing in women during the third trimester of
pregnancy or early post-partum period, is a rare cause of hypopituitarism and pituitary
enlargement. A 39 year-old woman presented in the 37th week of pregnancy with bilat-
eral heteronymous quadrantanopsia, CT indicative of tumorous mass and symptoms of
hypopituitarism with decreased thyroid hormone and thyrotrophin levels, and low nor-
mal level of cortisol. After the birth of a healthy male child the patient breastfed for 10
days, sight disturbances disappeared, but amenorrhea persisted. Upon admittance the
visual field showed no abnormalities. MR of the sellar region confirmed previous CT
findings. Endocrinological testing confirmed secondary hypothyroidism and cortisol
deficiency, normal levels of prolactin with satisfactory reaction to thyroliberin. Histol-
ogy showed mononuclear infiltration, and immunohistochemistry revealed T-cells (CD3)
at the borders, and B-cells (CD20) in the follicular center. Due to enlargement of the pitu-
itary associated with hypopituitarism, an incorrect diagnosis of a tumor could be made.
Introduction
Lymphocytic adenohypophysitis (LH)
was first described in 1962 by Goudie and
Pinkerton. Subsequently there have been
approximately 130 cases1 described in lit-
erature. It is an uncommon, but increas-
ingly recognized cause of pituitary en-
largement, diagnosed primarily in wo-
men in the last trimester of pregnancy or
in the early postpartum period (about
90% of all cases), and is often associated
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with a mild elevation of blood prolactin
level2. LH may also occur in premeno-
pausal women with no recent history of
pregnancy,3,4 postmenopausal women,5
adolescents6,7 and even in men8–11.
LH is a rare autoimmune inflamma-
tory process of the pituitary gland caus-
ing pituitary expansion with hypopitui-
tarism and closely mimicking features of
a pituitary adenoma. The presenting
symptoms are typically related to supra-
sellar extension and partial or panhypo-
pituitarism. The hormonal deficits may
be atypical with, most often, selective loss
of either adrenocorticotrophic (ACTH) or
thyroid stimulating hormone (TSH). Ac-
quired isolated deficiencies of any pitu-
itary hormone are not uncommon, and
several authors have suggested that LH
may cause them12,13. Some of them, like
secondary adrenal insufficiency can be fa-
tal without proper treatment. In the early
stage, the pituitary gland is enlarged,
mimicking tumor, and computed tomog-
raphy (CT) or magnetic resonance imag-
ing (MRI) cannot be used as procedures
for the ultimate diagnosis14. As it has
been suggested that pregnancy neither
initiates formation of prolactinomas nor
accelerates their growth,15 thus the prob-
ability that the diagnosis in such circum-
stances is LH increases.
In the later stages, the gland may at-
rophy, leaving an empty sella, as occurs
in Sheehan's syndrome. Recovery from
hypopituitarism has been described, but
is uncommon16,17. An autoimmune cause,
possibly involving both humoral and cell-
mediated mechanisms, has been postu-
lated but has not been proven yet18. Sup-
porting data include isolation of antipi-
tuitary antibodies, female predominance
and association with other autoimmune
disorders,19 but antipituitary antibodies
have not been documented in all patients
with proven autoimmune hypophysitis.
The natural history and pathogenesis
of LH remains poorly understood. The
first case of preoperatively suspected and
steroid-treated adenohypophysitis was
described in 199220. A review of literature
suggests that conservative treatment
may be given in suspected cases of lym-
phocitic hypophysitis, if the vision of the
patient is not threatened. A transsphe-
noidal stereotactic biopsy of the pituitary
may be performed if the patient does not
improve or deteriorates, thus avoiding
open exploration of the sella in selected
cases.
Case Report
In February 1998, a 39-year-old wo-
man was admitted to the University Hos-
pital »Sestre milosrdnice« – 4 months af-
ter her second delivery. Her family and
personal history revealed no abnormali-
ties, but she had an interesting gyne-
cological history: 1994 she had a missed
abortion, and 1997 she delivered by
Caesarin section a healthy male child. In
the 37th week of her second pregnancy
she complained of visual disturbances,
mild headaches, exertion intolerance,
muscle and joint pain. Due to mentioned
disturbancies she was admitted to the
Gynecological Department in local hospi-
tal. She was found to have bilateral hete-
ronymous quadrantanopsia.
Endocrinological evaluation revealed
low levels of blood thyroxin (T4) 45 nmol/l
(normal values 50–165 nmol/l), blood tri-
iodothyronine (T3) was 0,7 nmol/l (normal
values 1.1 –2.8 nmol/l), blood TSH level
was 0.1 mI/l (normal values 0.1–4 mIJ/l),
normal basal blood PRL level 20 ng/ml
(normal values 5–30 ng/ml) and a low
level of blood cortisol 95 nmol/l (normal
values 138–800 nmol/l). After therapy
(ordered by anaesthesiologist) with ste-
roids (hydrocortisone Cortef 2 10 mg)
and thyroid hormone (Levothyroxinum a
50  g), she delivered by Caesarin section
a healthy male child. She breastfed for 10
days only, sight disturbances disappear-
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ed, and amenorrhea persisted. One month
after delivery she felt dizziness and gen-
eral weakness.
CT of the sellar region showed a supra-
sellar spreading structure typical for ma-
croadenoma.
Because her physical condition deteri-
orated, she was admitted to our hospital.
Upon admittance to the hospital (Feb-
ruary 1998) the visual field was normal,
she suffered from mild hypotension (100/
70 mmHg), her skin was pale and dry
(mild features of hypothyreosis). Other
clinical findings revealed no abnormali-
ties.
Magnetic resonance imaging (MRI) of
the sellar region confirmed a homoge-
neously enhancing structure measuring
16 12 mm with suprasellar extension,
atypical but indicative of a macroade-
noma (Figure 1a and 1b).
Hormonal tests confirmed secondary
hypothyroidism (T3=0.7 nmol/l, T4=49
nmol/l) and cortisol deficiency (24-hour
urinary cortisol=75 nmol/l, blood corti-
sol=140 nmol/l) with normal basal levels
of PRL and satisfactory response to thy-
roliberin17. Anterior pituitary function
was assessed by measurement of blood
ACTH, TSH, growth hormone (GH), lu-
theotropic hormone (LH), follicle stimu-
lating hormone (FSH), T4, estradiol, cor-
tisol and progesteron. All hormones were
determined by radioimmunoassay (RIA)
method21.
In February 1998, transsphenoidal ex-
tirpation was performed. The tumorous
tissue showed solid consistency atypical
for adenomatous tissue, the mass was
spreading into sellar and suprasellar
structures. Ex tempore histological anal-
ysis of the extirpated tissue was not pos-
sible at the time.
Histopathological examination of the
parafine sections of the lesion showed ex-
tensive mononuclear infiltration of the
pituitary tissue. Plasma cells and lym-
phocytes formed follicles with germinal
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Fig. 1a. T1-weighted post-contrast magnetic resonance image in the sagittal plane shows
homogenous intense enhancement of the intrasellar mass (white arrow). The optic chiasm
(black arrow) is compressed and displaced. The pituitary stalk (white arrowhead) is well seen.
Fig. 1b. T1-weighted post-contrast image in the coronal plane again shows dense, homogenous
enhancement of the intrasellar mass (white arrow). The pituitary stalk is depicted along with
residual normal-appearing pituitary tissue (white arrowhead).
644
B. Vizner et al.: Lymphocitic Adenohypophysitis, Coll. Antropol. 26 (2002) 2: 641–650
Fig. 2. Lymphocytic adenohypophysitis forming follicle and with
aviable adenphypophysal cells, Mallory X 200.
Fig. 3. Lymphocytic adenohypophysitis, lymphatic follicle,
immunohistochemical stain CD20, APAP X 400.
centers (Figure 2). The neurohypophysis
was uninvolved, morphologically normal.
The immunoperoxidase technique of
Sternberger22 showed diffuse presence of
immunoreactive prolactin, CD20 positi-
vity was observed in follicular centers
(Figure 3), and lutheotropic hormone was
shown within remaining pituitary cells.
Immunohistochemistry revealed CD3 (Fi-
gure 4) and CD8 positive T cells at the pe-
riphery of lymphatic follicles and in the
interfollicular areas. Diffuse positivity for
CD45 was observed in the whole lesion.
Tissue samples were fixed in 10% buf-
fered formalin, embedded in parafin wax
and 5 mm sections were routinely stained
with hematoxylin and eosin (H-E), the
Mallory trichrome method and periodic-
acid Schiff (PAS) reaction. For analysis of
CD3, CD8, CD20 and CD45 the alkaline
phosphatase anti-alkaline phosphatase
(APAAP) method was used (the source of
used antibodies is DAKO, Denmark).
Over the next few months, while taking
hormonal replacement therapy, all pitu-
itary functions gradually recovered.
Discussion
Although the classic cause of postpar-
tum hypopituitarism is Sheehan’s syn-
drome, with improvements in obstetric
care, the most common cause may now be
lymphocytic hypophysitis.
Like other endocrine organs, the pitu-
itary may also be affected by an autoim-
mune processes. Inflammation may be
present diffusely in the adenohypophysis.
This case presents the rare histological
form of lymphocytic adenohypophysitis
with formation of lymph follicles with
germinal centers without any process af-
fecting the neurohypophysis. Lymphocy-
tic hypophysitis may be primarily due to
a T-cell-mediated autoimmune inflamma-
tion of the pituitary gland, with little or
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Fig. 4. Lymphocytic adenohypophysitis, lymphatic follicle,
immunohistochemical stain CD3, APAP X 400.
no humoral immunity being generated,
but it also needs to be elucidated. In
about 30% of cases lymphocytic hypophy-
sitis coexists with other autoimmune
disorders24. The autoimmune hypothesis
is further supported by experimentaly in-
duced lymphocytic hypophysitis in rats25.
Serologic examination of women one
week following normal delivery demon-
strated that 18% developed antipituitary
antibodies suggesting that pregnancy
may induce reactions against the pitu-
itary gland in a potentially large group of
women26. It is possible that those women
with LH diagnosed due to visual defects
or hormonal changes represent only the
tip of the iceberg. Only individual cases
have been reported not to be related to
pregnancy, a few cases have been descri-
bed in men,20 but the occurrence of lym-
phocytic hypophysitis without associated
pregnancy is more frequent than previ-
ously considered. Pestell et al.27 sugges-
ted that some alleles (A2 C4A3 C4B1
BfF1 BfS DR4 DRW53 DQW3) may pre-
dispose Caucasians to develop thyroidi-
tis, IDDM and less commonly antipitui-
tary antibodies, and rarely the emergen-
ce of LH.
In cases of LH not associated with
pregnancy, there was a history of ante-
cedent viral illnesses. Possibly an altered
immune reaction to viral antigens cross
reacted with the pituitary tissue suggest-
ing LH may be the final result of several
combinations of genetic background and
viral antigens.
Pituitary antibodies have been detect-
ed in sera of patients with hypopitui-
tarism or other endocrine diseases28. Me-
thodological problems have, however, ham-
pered the characterization of pituitary
autoantigens. Recently, immunoblotting
with human pituitary proteins29 allowed
detection and characterization of pituita-
ry autoantibodies in sera of patients with
biopsy-proven lymphocytic hypophysi-
tis30. Moreover, Stromberg et al.31 have
by immunoblotting identified autoanti-
bodies against pituitary cytosolic protein
in significantly high frequencies in sera
of patients with partial or total hypo-
pituitarism and also in sera of their rela-
tives. The possibility of a hereditary im-
munological pituitary process causing
partial or panhypopituitarism in some
patients can not be excluded.
Clinical presentation is typical for a
pituitary mass with suprasellar exten-
sion and either partial hypopituitarism
or panhypopituitarism. Concerning the
hormonal status, hyperprolactinemia has
been reported in about 50% of patients.
Possible causes of elevated PRL include
either the disruption of the pituitary
transport of prolactin inhibitory factor by
a large mass compressing the pituitary
stalk, or a direct effect of the inflamma-
tory process on the lactotrophic cells, or a
lactotroph-stimulating antibody arising
as a consequence of the inflammatory
process2,27. However, elevated blood lev-
els of other anterior pituitary hormones
are very rarely described. Most patients
with lymphocytic hypophysitis have per-
manent partial hypopituitarism or pan-
hypopituitarism, but elevations of IGF-I
and GH levels in the peripartum patient
have also been reported32. The diagnosis
remains difficult when CT scanning
shows only non-specific features of a con-
trast-enhancing pituitary mass, and an-
giography shows only non-vascularity. In
the study by Ahmadi et al.14 the MR-im-
aging appearance of lymphocytic hypo-
physitis was analyzed. The involved pitu-
itary glands were typically enlarged, and,
in some cases, lobulated, without signal
abnormalities on precontrast T1-weigh-
ted images. The postcontrast images re-
vealed intense enhancement of the entire
gland in patients, which was extending
into the pituitary stalk in most cases. In
some patients, the contrast-enhancement
was also spreading along the leptome-
ninges and dura, adjecent to the hypo-
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thalamus, and in the sellar region. In
comparison, most cases of pituitary ade-
noma showed a typical alteration in sig-
nal intensity on both pre- and postcon-
trast MR images but without enhance-
ment of the adjacent dura mater. In a ma-
jority of patients with histologically
proven LH, surgical reports showed dural
changes consisting of conspicuous adhe-
sions to the adjacent abnormally firm pi-
tuitary mass. However, in pituitary ade-
nomas complicated by hemorrhage, ne-
crosis or infarction, surgical or pathologic
findings were similar to those of adeno-
hypophysitis. Concerning all these facts,
an intensly enhancing mass associated
with strips of enhancing dura mater adja-
cent to the mass are valuable clues in the
preoperative differentiation of adenohyo-
pohysitis from typical pituitary adenoma.
If the clinical findings and MR imag-
ing features are consistent with the diag-
nosis of lymphocytic adenohypophysitis
(and if there is no visual field defect), a
therapeutic trial with steroids is justi-
fied. Additionally, abnormal gallium-67
uptake33 in the lesion, a positive response
to a steroid therapy, and resolution of
symptoms in the acute stage with shrink-
ing of the lesion on neuroimaging could
indicate the correct diagnosis had been
made. Such conservative management
however, should not be extended too long
if the pituitary lesion does not respond to
this regimen.
The question is, if the diagnosis of
lymphocytic hypophysitis can be made
with MR imaging, is a biopsy still neces-
sary?
The diagnosis is resting on histolo-
gical examination, so biopsy may be need-
ed to establish the correct diagnosis if a
trial of steroid therapy fails.
Histological examination of the mass
usually shows normal pituitary tissue in-
filtrated with lymphocytes (confirmed by
leucocyte common antigen stain) and/or
plasma cells with a small number of neu-
trophils, sometimes germinal center –
like lymphoid follicles, and strands of fi-
brous tissue27. Immunohystochemical
staining with a panel of anterior pitu-
itary hormones identifies the presence of
normal anterior pituitary endocrine cells
with or without apparent selective loss of
a specific cell type.
A firm diagnosis of LH can be made
only histologically, and it may coexist
with normal pituitary tissue. Sometimes
only a complete removal of a pituitary
mass gives an accurate tissue diagnosis.
It is very difficult to rely on a specific
immunological test for autoimmune hy-
pophysitis; the results of immunoflores-
cence on post mortem glands have gener-
ally been disappointing. Crock et al.29
described a new approach to the detection
of antipituitary autoantibodies by immu-
noblotting. It was used to identify at least
two target autoantigens in LH,30 cytosolic
proteins of 49 and 40 kDa. It is specu-
lated that the 49 kDa autoantigen might
be related to ACTH deficiency due to cor-
ticotroph destruction. ACTH deficiency,
as already mentioned, is the most promi-
nent feature of lymphocytic hypophysitis
and may be seen isolated34. As mentioned
earlier, LH may be associated with other
autoimmune disorders: adrenalitis, atro-
phic gastritis, pernicious anemia, lym-
phocytic parathyroiditis and isolated
ACTH deficiency19,41–43. In 1962., Goudi
and Pinkerton reported a case of a young
woman with histologically confirmed Ha-
shimoto’s thyroiditis and lymphocytic in-
filtration of the adenohypophysis. A case
of LH is also described in a patient with
Graves disese and diabetes mellitus44. Mc
Connon et al.45 reported a case of sparsely
granulated growth hormone cell adeno-
ma associated with lymphocytic adenohy-
pophysitis.
The majority of authors agreed that
hormone replacement is necessary al-
though there is increasing evidence of
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some spontaneous pituitary function re-
covery in the short-to-medium term. The
pituitary function may ultimately nor-
malize in any case after corticosteroid
treatment.
However, the recommendations have
been to avoid major resection whenever
possible, because of the self-limited cour-
se46 or to delay surgery if vision is not
compromised. If firm adhesions are en-
countered during surgery, and examina-
tion of frozen sections reveals only lym-
phocytes without any evidence of tumor
(assuming there is no extensive hemor-
rhage or necrosis), surgery should be lim-
ited to biopsy only or, if needed, decom-
pression of the optic chiasm47. To perform
a limited surgical biopsy for obtaining a
histological diagnosis and to follow the
evolution of the mass with MRI or CT
scan may be the reasonable approach.
The course of the disease can some-
times be insidious, and recurrence can
precipitate severe pituitary and hypotha-
lamic damage48,49.
Conclusion
1. Inflammatory lesions of the pitu-
itary gland have been increasingly recog-
nized in the past decade and several indi-
cators suggest that this rarely diagnosed
condition is probably more common than
previously suspected.
2. The entity should be suspected in
young females either during pregnancy
or immediately post partum with persis-
tent malaise in whom hypocortisolaemia
and/or hypothyroidism may be found.
3. In persons at greater risk for LH
(those with other autoimmune endocrine
diseases or postpartal women) who de-
velop a severe, unexplained illness, con-
servative, supportive treatment with or
without surgical decompression is gener-
ally favored over aggressive and exten-
sive surgical resection resulting in hypo-
pituitarism.
4. Glucocorticoids have a diagnostic,
as well as a therapeutic role (prolactino-
ma will not change after steroid therapy),
so this will allow further differentiation
of these two entities.
5. The long-term endocrinological and
radiological follow-up may be necessary
in all suspected, as well as in proven
cases of LH. Recurrent cases should be
promptly treated with steroids when a
definitive histological diagnosis has been
confirmed.
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LIMFOCITNI HIPOFIZITIS KOJI SIMULIRA PITUITARNI
ADENOM U TRUDNICA
S A @ E T A K
Limfocitni hipofizitis, koji se primarno javlja kod `ena u tre}em trimestru trudno}e
i poslijepartalno, rijedak je uzrok hipopituitarizma i uve}anja hipofize. 39-godi{nja
bolesnica, u 37-om tjednu trudno}e prezentirala se simptomima bilateralne heteronim-
ne kvadrantanopsije te simptomima hipopituitarizma, a CT-om selarnog podru~ja vi-
zualizirala se tumorska masa. Nakon poroda zdravog mu{kog novoro|en~eta i perioda
dojenja od 10 dana, nestalo je smetnji vida, no amenoreja je i dalje perzistirala. Po
primitku u na{u ustanovu nisu utvr|eni ispadi u vidnom polju, no na MR-u selarnog
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podru~ja vizualiziran je makroadenom sa supraselarnim {irenjem. Rezultati endokri-
nolo{kog testiranja upu}ivali su na sekundarni hipotiroidizam i insuficijenciju korti-
zola, dok su vrijednosti prolaktina, kao i njegov odgovor na tiroliberin bile uredne. Pa-
tohistolo{kom verifikacijom postavila se dijagnoza limfocitnog adenohipofizitisa s lim-
fati~nim folikulima gra|enim od (CD 3) T i (CD 20) B limfocita.
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